Dynatronics Corporation reported a significant decline in financial performance for the fiscal year ending June 30, 2025, with net sales decreasing by 15.8% to $27.4 million, down from $32.5 million in the previous year. The decrease was primarily attributed to reduced demand for orthopedic soft bracing products and a decline in overall volume from original equipment manufacturer (OEM) customers. Gross profit also fell by 21.3% to $6.0 million, representing 21.9% of net sales, compared to 23.5% in the prior year. The company recorded a net loss of $10.9 million, a substantial increase from the $2.7 million loss reported in fiscal 2024.
In terms of operational changes, Dynatronics faced significant impairment charges totaling $8.1 million, which included $7.1 million related to goodwill and $950,000 for intangible assets. These impairments were driven by a decline in the carrying value of certain assets, reflecting the company's ongoing struggles with profitability and revenue generation. The company’s total assets decreased to $15.4 million from $25.9 million, largely due to these impairments and a reduction in cash and cash equivalents, which fell to $326,000 from $484,000.
Dynatronics has been actively pursuing strategic initiatives to address its financial challenges. The company is transitioning the production of most of its therapeutic modalities from contract manufacturers to in-house operations, aiming to reduce costs and improve quality control. Additionally, the company is evaluating its inventory position to mitigate excess exposure and is focused on enhancing sales efforts to drive revenue growth. As of June 30, 2025, Dynatronics employed 88 full-time staff, with 40% of its workforce covered by a collective bargaining agreement set to expire in February 2028.
Looking ahead, Dynatronics has outlined a business plan for fiscal 2026 that includes enhancing partnerships with key accounts, improving operating profitability through disciplined product management, and pursuing acquisition opportunities in its core markets. However, the company has raised substantial doubt about its ability to continue as a going concern due to ongoing operating losses, negative cash flows, and reduced liquidity. The company is currently working on a comprehensive plan to improve its financial situation, but there are no guarantees of success.
About DYNATRONICS CORP
Dynatronics Corporation designs, manufactures, and sells high-quality medical devices and restorative products for physical therapy, orthopedics, pain management, and athletic training. Its product portfolio includes orthopedic supports, treatment tables, therapeutic modalities, and clinical supplies, serving healthcare providers, clinics, hospitals, and sports organizations. The company emphasizes trusted brands, regulatory compliance, and distribution partnerships to deliver innovative solutions in the healthcare industry.
About 10-K Filings
A 10-K form is a comprehensive annual report that public companies in the United States must file with the SEC, providing a detailed overview of the company's financial condition, performance, and business strategies.
Key points about the 10-K:
- Frequency: Filed annually, typically within 60 to 90 days after the end of the company's fiscal year.
-
Content: It includes:
- Detailed financial statements audited by an independent accounting firm
- Management's Discussion and Analysis (MD&A) of financial condition and results
- Description of the company's business, properties, and legal proceedings
- Risk factors and market risks
- Executive compensation and corporate governance information
- Importance: Considered the most comprehensive and important document a public company files with the SEC.
- Length: Often exceeds 100 pages due to its extensive and detailed nature.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.